Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation.
Bhargava P, Smith MD, Mische L, Harrington E, Fitzgerald KC, Martin K, Kim S, Reyes AA, Gonzalez-Cardona J, Volsko C, Tripathi A, Singh S, Varanasi K, Lord HN, Meyers K, Taylor M, Gharagozloo M, Sotirchos ES, Nourbakhsh B, Dutta R, Mowry EM, Waubant E, Calabresi PA. Bhargava P, et al. Among authors: taylor m. J Clin Invest. 2020 Jul 1;130(7):3467-3482. doi: 10.1172/JCI129401. J Clin Invest. 2020. PMID: 32182223 Free PMC article.
Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis.
Gharagozloo M, Smith MD, Sotirchos ES, Jin J, Meyers K, Taylor M, Garton T, Bannon R, Lord HN, Dawson TM, Dawson VL, Lee S, Calabresi PA. Gharagozloo M, et al. Among authors: taylor m. Neurotherapeutics. 2021 Jul;18(3):1834-1848. doi: 10.1007/s13311-021-01088-5. Epub 2021 Jul 14. Neurotherapeutics. 2021. PMID: 34260042 Free PMC article.
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.
Gharagozloo M, Galleguillos D, Jank L, Sotirchos ES, Smith MD, Garton T, Kumar S, Hussein O, Potluri S, Taylor M, Siu C, Mace JW, Dawson T, Dawson VL, Lee S, Calabresi PA. Gharagozloo M, et al. Among authors: taylor m. Neurotherapeutics. 2023 Jul;20(4):1229-1240. doi: 10.1007/s13311-023-01390-4. Epub 2023 Jun 9. Neurotherapeutics. 2023. PMID: 37296356 Free article.
Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.
Gharagozloo M, Smith MD, Jin J, Garton T, Taylor M, Chao A, Meyers K, Kornberg MD, Zack DJ, Ohayon J, Calabresi BA, Reich DS, Eberhart CG, Pardo CA, Kemper C, Whartenby KA, Calabresi PA. Gharagozloo M, et al. Among authors: taylor m. Acta Neuropathol. 2021 Nov;142(5):899-915. doi: 10.1007/s00401-021-02366-4. Epub 2021 Sep 6. Acta Neuropathol. 2021. PMID: 34487221 Free PMC article.
Clinical and Imaging Characteristics, Care Pathways, and Outcomes of Traumatic Epidural Hematomas: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study.
Pisică D, Volovici V, Yue JK, van Essen TA, den Boogert HF, Vande Vyvere T, Haitsma I, Nieboer D, Markowitz AJ, Yuh EL, Steyerberg EW, Peul WC, Dirven CMF, Menon DK, Manley GT, Maas AIR, Lingsma HF; CENTER-TBI Participants and Investigators. Pisică D, et al. Neurosurgery. 2024 May 21. doi: 10.1227/neu.0000000000002982. Online ahead of print. Neurosurgery. 2024. PMID: 38771081
Doxycycline for the treatment of nodding syndrome: a randomised, placebo-controlled, phase 2 trial.
Idro R, Ogwang R, Anguzu R, Akun P, Ningwa A, Abbo C, Giannoccaro MP, Kubofcik J, Mwaka AD, Nakamya P, Opar B, Taylor M, Nutman TB, Elliott A, Vincent A, Newton CR, Marsh K. Idro R, et al. Among authors: taylor m. Lancet Glob Health. 2024 May 13:S2214-109X(24)00102-5. doi: 10.1016/S2214-109X(24)00102-5. Online ahead of print. Lancet Glob Health. 2024. PMID: 38754459 Free article.
9,758 results